Full-service CRO STATKING Clinical Services is a long-standing full-service CRO with expertise across protocol development, monitoring, data management, biostatistics and regulatory submissions, presenting opportunities to sell expanded services to biotech and pharma clients seeking end-to-end trial support.

Regulatory Expertise The firm emphasizes adherence to Good Clinical Practice and regulatory approvals for devices, drugs and biologics, suggesting a sales angle around quality assurance, compliance audits, and rapid regulatory submission support for risk-averse sponsors.

Therapeutic Breadth A diverse therapeutic portfolio including radiopharmaceuticals, oncology, CNS, women’s health, rare diseases and more creates cross-sell potential into sponsors with compounds spanning multiple indications or needing specialized study designs and safety monitoring.

Mid-market Focus With 11-50 employees and revenue in the 10–25 million range, SCS sits in the mid-market CRO segment, offering a compelling value proposition to medium-sized biotech firms seeking flexible, hands-on clinical development partnerships without large-bore CROs.

Digital Presence Active digital presence via LinkedIn, YouTube and Google Analytics indicates readiness for outbound digital outreach, thought leadership, and target account prospects in biotech hubs to nurture inbound inquiries and accelerate lead generation.